Huakang Biomedical Holdings Company Limited (8622.HK) HKSE

0.41

+0.01(+2.50%)

Updated at December 24 12:08PM

Currency In HKD

Huakang Biomedical Holdings Company Limited

Address

Effectual Building

Wan Chai,

Hong Kong

Phone

852 2202 8988

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

91

First IPO Date

December 13, 2018

Key Executives

NameTitlePayYear Born
Chunguang ZhangChief Executive Officer & Executive Director781,8551968
Lai Yin PoonChief Financial Officer, Compliance Officer & Executive Director734,4371972
Xunyong ZhouExecutive Director01975
Lai Ki ChauFinancial Controller & Company Secretary01984
Yujing ZhangExecutive Chairman01984

Description

Huakang Biomedical Holdings Company Limited, an investment holding company, engages in the research, development, manufacture, marketing, and sale of in-vitro diagnostic (IVD) reagents in the People's Republic of China. It offers male and female fertility IVD, parasite antibody detection, and Epstein-Barr virus antibody detection reagents; auxiliary reproductive supplies and equipment; and healthcare products and supplements under the Nutronic brand to customers, as well as through online and offline platforms and channels. The company sells its products directly to hospitals and medical institutions, as well as to distributors. Huakang Biomedical Holdings Company Limited was founded in 1992 and is headquartered in Wan Chai, Hong Kong.